The Master of Public Health (M.P.H.) degree is designed for those who wish to acquire knowledge and skills necessary for epidemiologic practice and research. This degree will be appropriate for persons interested in a career studying the relationship of risk factors to a variety of disease, injury and other health-related states.
Graduates are qualified to work and provide leadership in state, federal and global health agencies such as the Centers for Disease Control and Prevention (CDC), the National Institute for Occupational Safety and Health (NIOSH), hospitals, infection control departments in multiple industries, academic health centers and other healthcare organizations, research institutions, foundations, insurance and managed care organizations and pharmaceutical and biotechnology companies.
Course Delivery OptionsOn-campus
Program Application RequirementsResume/CV, Supplemental Application, 3 Letters of recommendation, Personal Statement
Graduate Program Application Requirements
If you are ready to apply to WVU School of Public Health, the admissions team is here to assist you. The School of Public Health is CEPH accredited, and we participate in SOPHAS (Schools of Public Health Application Service). M.P.H. admissions is a two-step process. All applications must be submitted through the national SOPHAS service, and applicants must also submit a WVU graduate application.
Program Application Test RequirementsGRE
Fall DeadlineFebruary 15
English Proficiency Requirements
All applicants whose first language is not English must provide proof of English language proficiency. WVU accepts either the TOEFL or the IELTS for this purpose. Learn more about our English language proficiency requirements.
WVU is accredited by the Higher Learning Commission.
Dr. Baqiyyah Conway
Dr. Conway is an Assistant Professor of Epidemiology. She came to WVU from a post-doctoral fellowship in the Division of Epidemiology, Department of Medicine at Vanderbilt University Medical Center. She received her PhD in Epidemiology from the University of Pittsburgh and an MPH in Epidemiology from the University of North Texas Health Sciences Center at Fort Worth. Her research interests include the epidemiology of diabetes complications, diabetic neuropathy, and cardiovascular disease. At Vanderbilt University she conducted diabetes epidemiologic research in several large population studies. At the University of Pittsburgh she conducted research in all of the late complications type 1 diabetes, with a particular focus on cardiovascular disease and mortality. She also conducted research in hematologic factors in association with risk of adverse outcomes in type 1 diabetes. At both the University of Pittsburgh and Vanderbilt University she conducted clinical research in a non-invasive marker of advanced glycation end products in association with late complications of diabetes. Currently she is doing research using a de-identified electronic medical record database to investigate clinical risk factors for late complications of diabetes.